Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2009
11/17/2009CA2321198C 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
11/17/2009CA2272460C Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
11/17/2009CA2259583C Azolo triazines and pyrimidines
11/17/2009CA2230949C Synthetic peptides that inhibit il-6 activity
11/17/2009CA2206794C Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs
11/12/2009WO2009136629A1 Prophylactic/therapeutic agent for lifestyle-related diseases
11/12/2009WO2009136617A1 Process for production of compound having antagonistic activity on npyy5 receptor, and useful crystal
11/12/2009WO2009136611A1 Glutathione production enhancer, prophylactic/therapeutic agent for diseases associated with lack of glutathione, and food, beverage and feed
11/12/2009WO2009136370A1 Parenteral supplement with traceelemξntsfor treatment of i. a. sirs, burns selenium-defenciencies
11/12/2009WO2009136176A1 Compositions and methods for the treatment of fibromyalgia
11/12/2009WO2009103754A3 Novel use of 3,3'-diindolylmethane
11/12/2009WO2009081369A3 Method for treating fetal growth disorders
11/12/2009WO2009077500A3 Azolylmethyloxiranes, use thereof and agents containing the same
11/12/2009WO2009012901A3 Material compositions which comprise adult stem cells obtained from exocrine glandular tissue, in particular for use in regenerative medicine, e.g. for restoring injured or damaged myocardial tissue
11/12/2009US20090281633 Porous ceramic material and method of producing the same
11/12/2009US20090281310 Cinnamide compound
11/12/2009US20090281180 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester
11/12/2009US20090281164 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/12/2009US20090281158 Prodrugs of cc-1065 analogs
11/12/2009US20090281128 Caspase inhibitors and uses thereof
11/12/2009US20090281096 Cyclothiocarbamate derivatives as progesterone receptor modulators
11/12/2009US20090281072 Diaminopyrimidinecarboxamide Derivative
11/12/2009US20090281051 Carba-sugar amine derivative and glycolipid metabolic disorder treating agent containing the same as active ingredient
11/12/2009US20090281033 Control of radiation injury
11/12/2009US20090280193 Enerceutical mediated activation of the Alternative Cellular Energy (ACE) pathway in the therapy of diseases
11/12/2009US20090280181 Delivery of nucleic acid complexes from particles
11/12/2009US20090280102 Compositions for enhancing the antibacterial activity of myeloperoxidase and methods of use thereof
11/12/2009US20090280081 JAK/STAT pathway inhibitors and uses thereof
11/12/2009US20090280063 Novel pei-peg graft copolymer coating of iron oxide nanoparticles for inflammation imaging
11/12/2009CA2723133A1 Process for production of compound having antagonistic activity on npyy5 receptor, and useful crystal
11/11/2009EP2116543A1 Novel aminopyrimidine derivative as plk1 inhibitor
11/11/2009EP2116535A1 Glucokinase-activating substance
11/11/2009EP2116533A1 Glucokinase activator
11/11/2009EP2116526A1 Derivates of substituted tartaric aicd and usage for preparating beta secretase inhibitors
11/11/2009EP2116266A1 Percutaneously absorbable preparation, process for production thereof and method for percutaneous absorption
11/11/2009EP2116262A2 Gene detection assay for improving the likelihood of an effective response to an ErbB antagonist cancer therapy
11/11/2009EP2116257A2 Parenteral vaccine formulations and uses thereof
11/11/2009EP2116256A1 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same
11/11/2009EP2116250A1 Combination of an estrogen and an androgen for treating hormonal deficiencies in women undergoing estrogen replacement therapy
11/11/2009EP2116248A1 Compositions and Methods of Treatment of Cancer
11/11/2009EP2116241A1 Pharmaceutical composition
11/11/2009EP2116239A1 Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
11/11/2009EP2114942A1 Novel aminopyrimidine derivatives as plk1 inhibitors
11/11/2009EP2114896A1 Radioprotector compounds and related methods
11/11/2009EP2114398A1 Isosorbide mononitrate derivatives for the treatment of ocular hypertension
11/11/2009EP2010005B1 Treatment of poultry for reducing the feed conversion rate or for reducing the incidence of ascites
11/11/2009EP1603541B1 SOLUBLE HYALURONIDASE GLYCOPROTEIN (sHASEGP), PROCESS FOR PREPARING THE SAME, USES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF
11/11/2009EP1557407B1 Novel alpha-ketoamide derivatives and use thereof
11/11/2009EP1537104B1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
11/11/2009EP1482795B1 New immunoeffector compounds
11/11/2009EP1401451B1 Quinazoline derivatives which promote the release of parathyroid hormone
11/11/2009EP1397351B1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
11/11/2009EP1320369B1 A method of analgesia
11/11/2009EP1313734B1 Aza heterocyclic derivatives and their therapeutic use
11/11/2009EP1181048B1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
11/11/2009EP1174140B1 Chromanol glycosides for use in the treatment of dermopathy caused by ultraviolet light
11/11/2009CN101575335A Dehydrogenated silibinin substituted by meta-chlorobenzene formoxyl, preparation method and pharmaceutical applications thereof
11/11/2009CN101575333A Quinazoline derivatives and medical application thereof
11/11/2009CN101574552A Inhalation kit comprising inhalable powder of tiotropium
11/11/2009CN101574475A Polygonatum particle and preparation method thereof
11/11/2009CN101574395A Method for producing schisandra extract by adopting high voltage pulse electric field technology
11/11/2009CN101574364A Preparation capable of improving intelligence, height, athletic ability and immunity and preparation method
11/11/2009CN100558899C Growth hormone fusion protein
11/11/2009CN100558724C Sulphonic acid amide for regulating bast peptide activity and derivative thereof
11/11/2009CN100558715C Protein kinase inhibitors
11/11/2009CN100558712C Therapeutic molecules and methods-1
11/11/2009CN100558685C Extract from the pods of lupin seeds containing lupeol
11/11/2009CN100558410C Nucleic acids, polypeptides, and methods for modulating apoptosis
11/11/2009CN100558369C Therapeutical treatments
11/11/2009CN100558367C Method for enhancing the effectiveness of cancer therapies
11/11/2009CN100558359C Remedy for glomerular diseae
11/11/2009CN100558356C Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
11/11/2009CN100558350C Improved transdermal delivery system
11/11/2009CN100558340C Use of gourd oil for inhibiting s alpha-reductase activity
11/10/2009US7615677 Assessment method
11/10/2009US7615622 Methods and compositions for reducing heparan sulfate proteoglycan-mediated clearance of factor VIII
11/10/2009US7615573 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease
11/10/2009US7615564 Such as N5-[1-(2-chlorobenzyl)tetrahydro-1H-3-pyrrolyl]-5-isoquinolylamine; Rho kinase inhibitors; hypertension, asthma, angina pectoris, cerebrovascular contraction, peripheral circulatory disorder, threatened premature birth, glaucoma, vision disorders, autoimmune diseases, chronic renal failure
11/10/2009US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009US7615548 Method to inhibit ischemia and reperfusion injury
11/10/2009US7615543 Complexes with C-reactive protein (CRP) molecules; rheumatoid arthritis, juvenile chronic (rheumatoid) arthritis, ankylosing spondylitis, psoriatic arthritis, systemic vasculitis, polymyalgia rheumatica, Reiter's disease, Crohn's disease and familial Mediterranean fever
11/10/2009US7615540 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
11/10/2009US7615379 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer
11/10/2009US7615217 Modified fusion protein comprising an anti-EGFR immunoglobulin moiety and a cytokine polypeptide moiety linked together
11/10/2009CA2491632C Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases
11/10/2009CA2481482C Tropane derivatives as ccr5 modulators
11/10/2009CA2476257C O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
11/10/2009CA2459930C Method of treating middle ear infections
11/10/2009CA2416785C Novel arylethene-sulfonamides
11/10/2009CA2411572C 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
11/10/2009CA2410862C Factor viia inhibitory (thio)urea derivatives, their preparation and their use
11/10/2009CA2401637C N-(heterocyclyl)benzene- or - pyridinesulphonamides as antithrombotic and anticoagulant agents
11/10/2009CA2397593C Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
11/10/2009CA2396351C New therapeutic combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-one and neuroleptics for the treatment or prevention of psychotic disorders
11/10/2009CA2382117C 4-substituted piperidine compound
11/10/2009CA2378792C Aminothiazole derivatives and their use as crf receptor ligands
11/10/2009CA2371213C Inhibitors of carboxypeptidase u
11/10/2009CA2315262C Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
11/10/2009CA2280612C Amino acid-sugar composition
11/05/2009WO2009133951A1 Anti-perspiration antigen monoclonal antibody
1 ... 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 ... 1564